Why The British American Tobacco Investment In OrganiGram Is Important

OrganiGram Holdings Inc’s OGI stock is likely to re-rate following the investment by a subsidiary of British American Tobacco PLC BTI, according to Cantor Fitzgerald.

The OrganiGram Analyst: Pablo Zuanic maintained an Overweight rating for OrganiGram Holdings, while raising the price target from C$3.50 to C$6.

The OrganiGram Thesis: The latest deal for a 19.9% stake in OrganiGram makes British American Tobacco the third tobacco company to invest in cannabis, Zuanic said in the note.

“We think the OGI stock valuation should now reflect the potential for BATS to increase its stake in the future as well as a strengthened B/S that provides M&A optionality, room for potential international collaboration, and the potential for OGI to further bolster its already well-recognized product development and innovation capabilities,” he wrote.

“Following the C$221Mn investment, OGI will have cash holdings and short-term investments of C$296Mn, according to management. Only C$30Mn of the C$296Mn is to go for joint product development, so OGI should also have enhanced ability for M&A,” the analyst said.

OGI Price Action: Shares of OrganiGram had declined by 5.32% to $3.82 at the time of publication Friday.

(Image: OrganiGram Holdings)

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisPenny StocksPrice TargetReiterationSmall CapMarketsAnalyst RatingsCantor FitzgeraldPablo Zuanic
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.